← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2018Last known activity
Jan 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06101992Lead sponsorN/AJan 1, 2024
- NCT06101992Study chairN/AJan 1, 2024
- NCT06101992OfficialN/AJan 1, 2024
- NCT03791775Lead sponsorPhase 2Dec 1, 2018
- NCT03791775CollaboratorPhase 2Dec 1, 2018
Details
- Last known activity
- Jan 1, 2024